ConscienHealth

Ted Kyle and ConscienHealth work with experts to advance sound approaches to health and obesity, the biggest threat to America's health for this century.

ConscienHealth works with experts and organizations to advance sound approaches to health and obesity, the biggest threat to the health of America in this century. We advocate for evidence-based prevention and treatment. We help organizations develop strategies to advance new options from research to adoption in clinical practice and health policy. We develop strategies that are based on sound sci

ence, public policy, and a deep understanding of consumer needs. We help experts and advocates to educate the public and provide a voice for people affected by obesity.

04/24/2026

“The axis of scientific integrity has shifted to the Global South, where Latin American nations – including Brazil, Chile, Colombia, Mexico, Peru, and Uruguay – uphold food systems that are socially just and environmentally sustainable.”
https://conscienhealth.org/2026/04/24/has-the-u-s-given-up-global-leadership-on-nutrition-policy/

04/23/2026

This week, Medicare stepped up to ensure seniors will have access to GLP-1 obesity meds through 2027. But health plans seem to be having a tough time choosing to protect the health of their members instead of chasing plumper profits.
https://conscienhealth.org/2026/04/23/medicare-steps-up-on-obesity-care-will-health-insurers/

04/22/2026

Is a bad actor? Or an innocent bystander suffering guilt by association? A new review in Nature Metabolism says it is likely bad actor in our world of excess.
https://conscienhealth.org/2026/04/22/concerns-about-excessive-fructose-refuse-to-fade/

04/21/2026

Already, the food industry finds it necessary to adapt to shifting consumer behaviors as GLP-1s take hold. Alcohol, too. Is the $100-billion cannabis industry next?
https://conscienhealth.org/2026/04/21/are-glp-1s-prompting-a-recalibration-in-the-cannabis-industry/

04/20/2026

GLP-1 agonists have taken the world by storm – bringing a radical reconsideration of thinking about the role of medicines in obesity treatment. Richard DiMarchi and Matthias Tschöp suggest in a new paper that this is only a start.
https://conscienhealth.org/2026/04/20/glp-1-may-only-be-the-beginning-not-the-end-of-the-story

04/19/2026

A new systematic review of body composition in obesity medicine RCTs is out. In 65% of studies more than 25% of weight loss came from muscle. Perspective is essential. Attention, not reflexive recoil, is warranted.
HT: Annals of Internal Medicine
https://conscienhealth.org/2026/04/19/a-closer-look-at-body-composition-in-obesity-drug-trials/

04/18/2026

No two ways about it. Orforglipron delivering a 16% reduction in heart attacks, strokes, CV deaths, and hospitalizations in persons with obesity and diabetes is impressive. Topline results from Eli Lilly and Company.
https://conscienhealth.org/2026/04/18/foundayo-hits-the-mark-for-cutting-cardiovascular-events/

04/17/2026

If you want to think deeply about where emerging GLP-1 therapies are taking us, spend some time with this outstanding essay from Julia Belluz. She paints a complex picture with extraordinary skill, putting lived experiences front and center.
https://conscienhealth.org/2026/04/17/a-treasure-trove-of-food-for-thought-from-julia-belluz/

04/16/2026

New research in BMJ Open tells us that nutrition information dispensed by chatbots is notoriously unreliable. Three quarters of the time it is problematic.
https://conscienhealth.org/2026/04/16/your-chatbot-is-likely-not-a-reliable-source-on-nutrition/

04/15/2026

Fear mongers often dominate public discourse about artificial sweeteners. But if you stop and look at the data it tells a very different story from the strong feelings they convey. Two new studies.
https://conscienhealth.org/2026/04/15/strong-feelings-on-sweeteners-dont-match-the-data/

04/14/2026

The history of insulin has a thing or two to teach us about what's unfolding now with GLP-1s and their potential successors, says Liam Shaw in London Review of Books.
https://conscienhealth.org/2026/04/14/does-the-history-of-insulin-rhyme-with-glp-1s/

04/13/2026

“America has a new GLP-1 playbook,” writes Nicholas Florko in The Atlantic. Yep, ever so slowly, our discourse about GLP-1s is shifting from short-term (weight loss) to long term (better health). Wegovy and Foundayo tablets are sparking it.
https://conscienhealth.org/2026/04/13/glp-1-tablets-are-part-of-a-shift-in-discourse-about-obesity/

Address

Pittsburgh, PA
15241

Telephone

+1.412.206.9303

Website

http://www.conscienhealth.org/news

Alerts

Be the first to know and let us send you an email when ConscienHealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ConscienHealth:

Shortcuts

Want your practice to be the top-listed Clinic in Pittsburgh?